Shenyang Sheng Tak Technology Co., Ltd.   

As the leading technology of the third medical revolution, biotechnology, especially genetic technology, has triggered a global investment boom. The United States government and industry in the past 10 years, a total of nearly 2000000000 U. S. dollars for the use of microarray based research, development and industrialization. 2003, the United States in the Wall Street stock market in the most healthy biotech stocks, only Roche, in 1993 invested $2100000000 acquisition of gene technology companies, the stock market return to reach $23000000000 in revenue. 2003, Roche has two gene chip with drug metabolism related to the U.S. FDA approval, the future will continue to launch 6 kinds of gene detection chip. Such high investment in high return business opportunities to attract the world's attention. As the sales company of the Chinese company, the electronic science and Technology Co., Ltd. is mainly engaged in the management of the bio chip and its related biological products. It can provide all kinds of technical service and service for scientific research workers. Products and services include...